A new level of understanding of pigment cell biology and pathology will require the ability to culture and manipulate melanocyte stem cells (MCSCs) in vitro. In this issue, Nishikawa-Torikai et al. report progress toward this end. MCSCs isolated from mouse hair follicles can be expanded in vitro in a feeder-layer culture system. Application to human systems can be expected.
recent progress in mcScs is based on in vivo studies using genetically engineered mice
Major progress in skin MCSC research has been made over the past decade through the use of genetically engineered mice. Previously, melanocyte research was focused more on melanocyte development and the behavior of unsorted adult melanocytes. Nishikawa's group (Nishimura et al., 2002) first identified MCSCs in hair follicles (HFs) using genetically engineered mice with a LacZ reporter driven by the promoter of the early melanocyte-development gene, Dct . With these genetic tools and lineage-tracing strategies, they were able to verify MCSCs functionally, mapping the MCSC niche to the lower permanent portion of HFs (including the bulge). Later, also with the use of genetically engineered mice, researchers started to shed more light on the cell dynamics and regulation of MCSCs: quiescence, activation, differentiation, self-maintenance, response to injury, and interactions with neighbors (Nishimura et al., 2005; Inomata et al., 2009; Nishimura, 2011; Rabbani et al., 2011) .
MCSCs are activated, proliferate, and give rise to amplifying progeny only in early anagen (Nishimura et al., 2002) (Figure 1a ). It is suggested that this activation is dependent on c-Kit and Wnt/β-catenin signaling (Botchkareva et al., 2001; Rabbani et al., 2011) . The amplifying progeny colonize in the hair bulb, where they differentiate and transfer melanosomes to keratinocytes. The niche environment plays an active role in the activation and maintenance of MCSCs. For example, secreted Wnt ligands and transforming growth factor-β from bulge keratinocytes are vital to the activation and quiescent maintenance of MCSCs, respectively (Nishimura et al., 2010; Rabbani et al., 2011) . Failure to maintain MCSCs in their niche may cause premature MCSC depletion, leading to early hair pigment loss (Nishimura et al., 2005) . Together, these studies have added to our understanding of the identity, niche location, cell dynamics, and regulation of HF MCSCs (see also the recent review by Nishimura (2011)).
However, only a few studies have examined MCSC behavior in other mammals, including humans, because of the lack of a similar genetic methodology. As shown in keratinocyte research, the isolation and in vitro culture system for keratinocyte stem cells have helped to provide more insight into the behavior and regulation of keratinocyte stem cells. A method allowing the isolation and characterization of MCSCs will be important for the field of pigment cell biology and pathology.
Successful isolation of mouse mcScs
In this issue, Nishikawa's group tries to bridge this gap in melanocyte research. In a 2008 publication, the same group reported an in vitro culture system for embryonic melanoblasts using a feeder layer of XB2 keratinocyte and growth factors (e.g., stem cell factor, basic fibroblast growth factor) (Yonetani et al., 2008) . On the basis of this strategy, they now present in this issue a method to isolate and culture MCSCs from adult murine HFs ( Figure 1b ). Starting from a transgenic mouse (Dct tm1(Cre)Bee /CAG-CAT-GFP mouse strain) that specifically expresses green fluor escent protein in melanocytes for cell sorting, they found that only melanocytes from the lower permanent portion of anagen follicles are able to proliferate in vitro; melanocytes isolated from hair bulbs are not. When surface marker and side-scatter (SSC) profiles were characterized further, the investigators discovered that immature melanocytes in the lower permanent portion of HFs are c-Kit (Horikawa et al., 1999; Hartmann et al., 2008) . Why are infundibular and epidermal melanocytes unable to migrate and repopulate the empty niche during human hair graying? Whether this progressive loss of MCSCs in humans is an intrinsic defect of MCSCs or is caused by an alteration in the surrounding environment remains to be determined. Understanding the pathogenesis may help to develop methods for preventing the loss of-or even for restoring-MCSCs in hair graying.
In vitiligo under photochemotherapy, early work has suggested that amelanotic melanocytes in HFs proliferate, differentiate, and migrate out to interfollicular epidermis, leading to "follicular repigmentation" (Staricco, 1963; Cui et al., 1991) . However, whether this effect of phototherapy is through direct activation of HF MCSCs requires further investigation. It was observed that the follicular repigmentation under phototherapy seems to be independent of the hair cycle (Cui et al., 1991) . This contrasts with the current view in physiological HF pigmentation obtained from genetically engineered mice, that is, that MCSCs are activated only in early anagen (Nishimura et al., 2002; Rabbani et al., 2011) . How do we explain this treatment effect in humans? As suggested by Nishikawa-Torikai et al. (2011) , MCSCs themselves might not be equal. Hence, it is possible that some apigmented melanocytes in the human bulge might already be committed and are able to proliferate and differentiate in response to such phototherapy, even in telogen. (Figure 1c) . The method to isolate and culture murine MCSCs developed by Nishikawa's group brings us closer to a position in which we are capable of isolating and culturing human MCSCs for treatment, pharmaceutical testing, and pathophysiological investigation.
In summary, the breakthrough in culturing technology for murine MCSCs will allow further bench biomolecular perturbation and characterization. The in vitro studies will be complementary to results obtained in vivo. Furthermore, the concept and approach Nishikawa-Torikai et al. (2011) propose can be developed and applied to isolating human MCSCs. Their findings are expected to facilitate research in human melanocytes as well as clinical applications of MCSCs.
